Celebrating Colorado’s Life Sciences Ecosystem
The annual CBSA awards dinner highlights the spirit and drive of Colorado’s vibrant life sciences ecosystem. It brings together hundreds of leaders and innovators to applaud our successes and look ahead to the coming year.
17th Annual Awards Celebration – Register today!
CBSA looks forward to welcoming our life sciences community to our virtual Annual Awards on Wednesday, December 9, 2020 from 3:30-6:00pm MT! Mark your calendar to toast our collective accomplishments during our 17th annual celebration. During the pandemic, our ecosystem continued to grow and thrive. We will virtually celebrate the memorable milestones and incredible people behind Colorado’s health innovations.
2019 Award Winners
Rising Star of the Year
Securisyn Medical is preventing the common and costly complications of airway management in ventilated patients with SoliAIRity, an FDA 510(k) cleared Airway Stabilization System. Also nominated for the honor were: Bolder Surgical and Edgewise Therapeutics.
Additional honorees included:
Colorado Bioscience Institute Leadership Award
Agilent Technologies, AveXis and Tolmar collaborated with the Colorado Bioscience Institute to develop the future talent pipeline for life sciences in Colorado with the Pathways in Technology Early College High Schools (P-TECH) program. Their leadership and commitment will support Colorado life sciences workforce development with a focus on manufacturing.
Educator of the Year
Chelsea Magin, PhD, Assistant Professor in Medicine and Bioengineering at the University of Colorado, Anschutz Medical Campus. Chelsea is a dedicated educator and mentor, as an active member of the Colorado Bioscience Institute and the Research Experience for Teachers Program. She currently teaches the Bioengineering Department’s Regulatory Affairs course.
Deal of the Year – NEW Award in 2019!
Array BioPharma, a Colorado based company was founded in 1998 focused on the discovery, development and commercialization of targeted small molecule medicines to treat cancer and other diseases of high unmet need. In June 2019, Array was acquired by international biopharmaceutical company Pfizer for approximately $11.4 billion.